PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAG9. A total of 16 filers reported holding PDL BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.9%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SMH CAPITAL ADVISORS INC | 53,000 | $54,000 | 0.11% |
UNITED CAPITAL FINANCIAL ADVISORS, LLC | 37,000 | $3,760,000 | 0.02% |
XTX Topco Ltd | 18,463 | $46,000 | 0.02% |
SANDERS MORRIS HARRIS LLC | 13,000 | $13,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |